Bill
H 1234
Summary of H 1234: An Act relative to pharmacy benefit managers OverviewThis bill, H 1234, seeks to regulate the practices of pharmacy benefit managers (PBMs) in the state. PBMs ar
This bill, H 1234, seeks to regulate the practices of pharmacy benefit managers (PBMs) in the state. PBMs are third-party administrators of prescription drug programs for health plans and employers. The bill aims to increase transparency, fairness, and accountability in the PBM industry.
The main elements of the bill include:
PBM Licensure Requirement: The bill would require PBMs operating in the state to obtain a license from the state insurance commissioner. This is intended to provide regulatory oversight of PBM activities.
Pharmacy Reimbursement Standards: The legislation sets minimum reimbursement standards that PBMs must follow when paying pharmacies for dispensed drugs. This includes prohibiting PBMs from reimbursing pharmacies at rates below the pharmacies' wholesale acquisition costs.
Disclosure of Pricing and Rebate Information: PBMs would be required to regularly report to the state insurance commissioner on their pricing, fees, and rebate arrangements with drug manufacturers. This data would be made publicly available to increase transparency.
Ban on "Gag Clauses": The bill bans PBMs from including contractual provisions that prohibit pharmacists from informing patients when a prescribed drug could be purchased for a lower out-of-pocket cost.
Pharmacy Steering Restrictions: PBMs would be prohibited from requiring patients to use their own mail-order or specialty pharmacies, allowing patients more choice in where they fill prescriptions.
If enacted, this legislation would aim to address concerns about PBM practices that some stakeholders argue have increased prescription drug costs and reduced patient access and choice. Supporters say the bill will promote a more competitive and transparent PBM marketplace. Opponents argue the regulations could raise costs for health plans and lead to higher premiums.
The bill has been reported favorably by the committee and referred to the House Ways and Means Committee for further consideration.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
